Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range.
about
CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult disease.Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels.Role of New Functional MRI Techniques in the Diagnosis, Staging, and Followup of Gynecological Cancer: Comparison with PET-CT.Molecular approaches to personalizing management of ovarian cancer.Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers.A 10-gene expression signature of Notch pathway predicts recurrence in ovarian carcinomaDiagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patientsThe Significance of Serum CA-125 Elevation in Chinese Patients with Primary Budd-Chiari Syndrome: A Multicenter Study.Ovarian cancer biomarkers: a focus on genomic and proteomic findings.CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer.An outlook on ovarian cancer and borderline ovarian tumors: focus on genomic and proteomic findingsDual detection of cancer biomarker CA125 using absorbance and electrochemical methods.The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancerCA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study.Molecular signatures of ovarian cancer: from detection to prognosis.Correlation of cytohistlogical expression and serum level of ca125 in ovarian neoplasm.Variations in normal serum alpha-fetoprotein (AFP) levels in patients with testicular cancer on surveillance.microRNA and Ovarian Cancer.Prognostic evaluation of preoperative serum C-reactive protein concentration in patients with epithelial ovarian cancer.Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer.Comparison of the Serum Level of Cancer Antigen 125 and Human Epididymis Protein 4 in Ovarian Cancer Patients and Healthy Groups in Isfahan City.Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.Detection of the ovarian cancer biomarker CA-125 using chemiluminescence resonance energy transfer to graphene quantum dots.
P2860
Q34334247-47EAA55A-55B1-4737-A5A6-9537617CA168Q34762185-1D579E73-7A55-4EFD-8FAA-9607E4EDF650Q34838655-B2A56872-D3BC-4508-82AD-5FC726C1775FQ35725661-CE0A648F-35AF-4C50-97C4-15B35E8AF713Q35760160-4C28CB6B-5EAD-4AA8-A3A1-84AF15043156Q35924450-E8B1FBCF-E936-415D-B5EE-1615C2DE3F51Q35944512-3E65137D-A0C5-44BB-A04C-1AA62205A0DEQ36029023-33369B4F-124E-4BFB-BC75-FD1E40AB2DC7Q36104134-48AE02C3-EA5E-4EB6-AD34-AA1122D11420Q37119992-E629A3F9-A117-41E0-AB27-C24D6362297BQ37141531-A61450AA-C4ED-47C4-9E30-E6F9F5B230F8Q37260040-49D004C3-6753-454D-8E78-1E639DFAFE3CQ37275565-65196BBE-7F81-43D1-8918-104179D907FCQ37296114-3D7F2EEB-383E-4BEB-B8DC-04A374F2E9C6Q37345899-5E4F5A5A-E9E7-42F1-8A6E-BA07C858473AQ37685074-7AC0AAB1-3803-47BA-9651-685203752DD1Q37730502-C0098C79-3CE7-4493-957B-D5D0DAE016D6Q38049538-2FC871A6-B8AB-458F-9700-64C0C0A13B5BQ38667018-73667A04-993C-4860-AFAC-6CF0AB3A7CC8Q40774077-BED0334A-71C9-4A91-A196-10E16AEB7FBCQ45747254-6B970F33-A094-42E8-80EE-6D0E13670BD6Q47124965-E6E013CD-424F-4FF4-8FB1-5DC94D157BB2Q53305332-8953D210-AC84-47C1-8191-78A490DED97FQ53654158-A96CE882-1946-4719-A9EB-2F22B5538F3C
P2860
Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk of epithelial ovarian can ...... evels within the normal range.
@ast
Risk of epithelial ovarian can ...... evels within the normal range.
@en
Risk of epithelial ovarian can ...... evels within the normal range.
@nl
type
label
Risk of epithelial ovarian can ...... evels within the normal range.
@ast
Risk of epithelial ovarian can ...... evels within the normal range.
@en
Risk of epithelial ovarian can ...... evels within the normal range.
@nl
prefLabel
Risk of epithelial ovarian can ...... evels within the normal range.
@ast
Risk of epithelial ovarian can ...... evels within the normal range.
@en
Risk of epithelial ovarian can ...... evels within the normal range.
@nl
P2093
P356
P1476
Risk of epithelial ovarian can ...... evels within the normal range.
@en
P2093
Antonio Santillan
Deborah K Armstrong
Ginger J Gardner
Marianna L Zahurak
Robert E Bristow
Robert L Giuntoli
Ruchi Garg
P304
P356
10.1200/JCO.2005.02.2582
P407
P577
2005-12-01T00:00:00Z